|
COPS7B expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.599100E-03 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.801470E-03 |
| Normal-vs-Stage2 |
2.743400E-01 |
| Normal-vs-Stage3 |
2.850400E-01 |
| Normal-vs-Stage4 |
1.013510E-02 |
| Stage1-vs-Stage2 |
4.955000E-01 |
| Stage1-vs-Stage3 |
7.497700E-02 |
| Stage1-vs-Stage4 |
6.175200E-01 |
| Stage2-vs-Stage3 |
6.917600E-01 |
| Stage2-vs-Stage4 |
3.594600E-01 |
| Stage3-vs-Stage4 |
1.032960E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.642320E-02 |
| Normal-vs-AfricanAmerican |
2.208400E-02 |
| Normal-vs-Asian |
3.35880000001954E-06 |
| Caucasian-vs-AfricanAmerican |
2.790200E-01 |
| Caucasian-vs-Asian |
1.539760E-03 |
| AfricanAmerican-vs-Asian |
4.514800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
8.715500E-03 |
| Normal-vs-Female |
9.782800E-03 |
| Male-vs-Female |
4.920600E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.639000E-03 |
| Normal-vs-Age(41-60Yrs) |
1.740240E-02 |
| Normal-vs-Age(61-80Yrs) |
7.205500E-02 |
| Normal-vs-Age(81-100Yrs) |
5.808400E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.116600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.758400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.257800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.855000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.654800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.329800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.349250E-01 |
| Classical-VS-Follicular |
3.046200E-01 |
| Classical-VS-Other |
2.724000E-01 |
| Classical-VS-Normal |
7.393900E-04 |
| Tall-VS-Follicular |
6.181000E-01 |
| Tall-VS-Other |
7.761600E-01 |
| Tall-VS-Normal |
4.493600E-01 |
| Follicular-VS-Other |
6.086600E-01 |
| Follicular-VS-Normal |
1.127570E-01 |
| Other-VS-Normal |
8.998400E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.255900E-03 |
| Normal-vs-N1 |
5.013000E-01 |
| N0-vs-N1 |
1.208800E-01 |
|
|
